Subtle brain abnormalities in adrenomyeloneuropathy;Anomalies cérébrales subtiles de l'Adrénomyé loneuropathie

Journal de Radiologie

Volumn 88, Issue 7-8 C1, 2007, Pages 957-961

  Teriitehau, C ^a,b   Adamsbaum, C ^c   Merzoug, V ^c   Kalifa, G ^c   Tourbah, A ^d   Aubourg, P ^c  

^a PERCY MILITARY HOSPITAL   (France)

^b Hôpital Saint Vincent de Paul ^*  (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Adrenomyeloneuropathy; MR, brain; Spectroscopy

Indexed keywords

ADOLESCENT; ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; BRAIN DAMAGE; BRAIN DISEASE; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SPECTROSCOPY; WHITE MATTER;

EID: 34548486286     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(07)89902-1     Document Type: Article

References (15)

1. Aubourg P, Mandel JL. X-linked adrenoleukodystrophy. Ann N Y Acad Sci 1996;804:461-76.
2. Menage P, Carreau V, Tourbah A, Fontaine B, Paturneau-Jouas M, Gout O, et al. Symptomatic heterozygotic adrenoleukodystrophy in adults. 10 cases. Rev Neurol (Paris) 1993;149:445-54.
3. Izquierdo M, Adamsbaum C, Benosman A, Aubourg P, Bittoun J. MR spectroscopic imaging of normal-appearing white matter in adrenoleukodystrophy. Pediatr Radiol 2000;30:621-9.
4. Fatemi A, Barker PB, Ulug AM, Nagae-Poetscher LM, Beauchamp NJ, Moser AB, et al. MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy. Neurology 2003;60:1301-7.
5. Kumar AJ, Kohler W, Kruse B, Naidu S, Bergin A, Edwin D, et al. MR findings in adult-onset adrenoleukodystrophy. AJNR Am J Neuroradiol 1995;16:1227-37.
6. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, Lemaitre A, Boureau F, Mayer M, et al. Brain MRI and electrophysiologic abnormalities in preclinical and clinical adrenomyeloneuropathy. Neurology 1992;42:85-91.
7. Galanaud D, Nicoli F, Le Fur Y, Roche P, Confort-Gouny S, Dufour H, et al. Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors. Ann Med Interne (Paris) 2002;153:491-8.
8. Korenke GC, Hunneman DH, Kohler J, Stockler S, Landmark K, Hanefeld F. Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters. Eur J Pediatr 1995;154:64-70.
9. Kaplan PW, Kruse B, Tusa RJ, Shankroff J, Rignani J, Moser HW. Visual system abnormalities in adrenomyeloneuropathy. Ann Neurol 1995;37:550-2.
10. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, Rocchiccioli F, Cartier N, Jambaque I, et al. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy. N Engl J Med 1993;329:745-52.
11. Lesca G, Vanier MT, Creisson E, Bendelac N, Hainque B, Ollagnon-Roman E, et al. X-linked adrenoleukodystrophy in a female proband: clinical presentation, biological diagnosis and family consequences. Arch Pediatr 2005;12:1237-40.
12. Pasco A, Kalifa G, Sarrazin JL, Adamsbaum C, Aubourg P. Contribution of MRI to the diagnosis of cerebral lesions of adrenoleukodystrophy. Pediatr Radiol 1991;21:161-3.
13. Tourbah A, Stievenart JL, Iba-Zizen MT, Lubetzki C, Baumann N, Eymard B, et al. Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Increase of choline compounds in normal appearing white matter. Arch Neurol 1997;54:586-92.
14. Eichler FS, Barker PB, Cox C, Edwin D, Ulug AM, Moser HW, et al. Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy. Neurology 2002;58:901-7.
15. Loes DJ, Fatemi A, Melhem ER, Gupte N, Bezman L, Moser HW, et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 2003;61:369-74.